Загрузка...
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
This phase II study aimed at determining the efficacy and safety of irinotecan combined with thalidomide in adults with recurrent glioblastoma multiforme (GBM) not taking enzyme-inducing anticonvulsants (EIACs). Adult patients (⩾18 years) with recurrent GBM with up to three relapses following surger...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Duke University Press
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2613824/ https://ncbi.nlm.nih.gov/pubmed/18314417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2007-060 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|